Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 22118442

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2011 Nov 26
First author
Récher C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2011 Nov 26;378(9806):1828-9. doi: 10.1016/S0140-6736(11)61269-5.
    note
    Source null
    related pmid
    22118432
    relationship
    Comment in
  2. citation
    Lancet. 2012 Apr 21;379(9825):1485-6; author reply 1486-7. doi: 10.1016/S0140-6736(12)60626-6.
    note
    Source null
    related pmid
    22521065
    relationship
    Comment in
  3. citation
    Lancet. 2012 Apr 21;379(9825):1486; author reply 1486-7. doi: 10.1016/S0140-6736(12)60627-8.
    note
    Source null
    related pmid
    22521067
    relationship
    Comment in

Authors and identifiers

  1. name
    Récher C
    type
    Author
  2. name
    Coiffier B
    type
    Author
  3. name
    Haioun C
    type
    Author
  4. name
    Molina TJ
    type
    Author
  5. name
    Fermé C
    type
    Author
  6. name
    Casasnovas O
    type
    Author
  7. name
    Thiéblemont C
    type
    Author
  8. name
    Bosly A
    type
    Author
  9. name
    Laurent G
    type
    Author
  10. name
    Morschhauser F
    type
    Author
  11. name
    Ghesquières H
    type
    Author
  12. name
    Jardin F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Récher C
    type
    Author
  2. name
    Coiffier B
    type
    Author
  3. name
    Haioun C
    type
    Author
  4. name
    Molina TJ
    type
    Author
  5. name
    Fermé C
    type
    Author
  6. name
    Casasnovas O
    type
    Author
  7. name
    Thiéblemont C
    type
    Author
  8. name
    Bosly A
    type
    Author
  9. name
    Laurent G
    type
    Author
  10. name
    Morschhauser F
    type
    Author
  11. name
    Ghesquières H
    type
    Author
  12. name
    Jardin F
    type
    Author
bibliography ids
  1. nci-bib-3d6265b7e9d9a625bb4c0120
book metadata
content sha256
c39d48262740a7fbe868c2ca391dc8c6c05a8fc00c7040cdf635eca6543df0bc
document type
citation
dois
  1. 10.1016/S0140-6736(11)61040-4
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:22118442
immutable id
pubmed:22118442@c39d48262740a7fbe868c2ca391dc8c6c05a8fc00c7040cdf635eca6543df0bc
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9806
name
Lancet (London, England)
nlm unique id
2985213R
pages
1858-67
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2011 Nov 26;378(9806):1828-9. doi: 10.1016/S0140-6736(11)61269-5.
    note
    Source null
    related pmid
    22118432
    relationship
    Comment in
  2. citation
    Lancet. 2012 Apr 21;379(9825):1485-6; author reply 1486-7. doi: 10.1016/S0140-6736(12)60626-6.
    note
    Source null
    related pmid
    22521065
    relationship
    Comment in
  3. citation
    Lancet. 2012 Apr 21;379(9825):1486; author reply 1486-7. doi: 10.1016/S0140-6736(12)60627-8.
    note
    Source null
    related pmid
    22521067
    relationship
    Comment in
outcomes validated
false
pmid
22118442
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
0ab363ddb619be21ccfc09e5053d3d6b0518b6fc672ca7677ba69229ef19763d
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2011 Nov 26
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22118442/
title
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice